News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Myeloma Paper of the Day, May 10th, suggested by Robert Orlowski
May 10, 2024, 16:40

Myeloma Paper of the Day, May 10th, suggested by Robert Orlowski

Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X:

“Myeloma Paper of the Day: Prospective biomarker study finds preexisting cytopenias and hyperferritinemia predict long duration of post-CAR T-cell cytopenias, which may relate to immune remodeling with shift in CAR-negative T-cell subsets following therapy.”

Source: Robert Orlowski/X

Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study

Authors: Xiang Zhou, Vivien Wagner, Lukas Scheller, Emilia Stanojkovska, Christine Riedhammer, Xianghui Xiao, Maximilian Johannes Steinhardt, Cornelia Vogt, Silvia Nerreter, Florian Eisele, Mara John, Umair Munawar, Sofie-Katrin Kadel, Julia Mersi, Anna Ruckdeschel, Sven Schimanski, Larissa Haertle, Johannes Waldschmidt, Seungbin Han, Max Topp, Johannes Duell, Hermann Einsele, Angela Riedel, K. Martin Kortüm, and Leo Rasche.

Myeloma Paper of the Day

Other insights by Robert Orlowski on OncoDaily.

Angela Riedel Anna Ruckdeschel cancer Christine Riedhammer Cornelia Vogt Emilia Stanojkovska Florian Eisele Hermann Einsele Johannes Duell Johannes Waldschmidt Julia Mersi K. Martin Kortüm Larissa Haertle Leo Rasche Lukas Scheller Mara John Max Topp Maximilian Johannes Steinhardt MD Anderson Cancer Center Myeloma Paper of the Day OncoDaily Oncology relapsed/refractory multiple myeloma Robert Orlowski Seungbin Han Silvia Nerreter Sofie-Katrin Kadel Sven Schimanski Umair Munawar Vivien Wagner Xiang Zhou Xianghui Xiao
Special Coverage
Blog
Jan 15, 2025, 13:20
Aruni Ghose: Meeting Prof. Vanita Noronha and Celebrating Global Collaborations
Blog
Jan 15, 2025, 13:19
Komal Jhaveri: Participating in Dry January as a personal commitment to my health
Blog
Jan 15, 2025, 13:18
Dana-Farber Cancer Institute - One of the first clinical trials in the US to test 'memory like' NK cells in ovarian cancer
Science
Jan 15, 2025, 13:17
Myeloma Paper of the Day, January 15th, suggested by Robert Orlowski
Career
Jan 15, 2025, 13:16
OncoInfluencers to Follow on Social Media: Dr. Komal Jhaveri
Blog
Jan 15, 2025, 13:07
Yan Leyfman: Using routine blood tests to predict immunotherapy response across multiple cancers
Blog
Jan 15, 2025, 13:05
Douglas Flora: Association of Cancer Care Centers just pledged to match $10,000 in donations to Firefighter Cancer Support Network
Blog
Jan 15, 2025, 13:03
Ellen Sigal: Ready to get back to work and continue fighting to ensure every patient has access to the most innovative medicines
Blog
Jan 15, 2025, 13:00
Ray Bai: Methods and Applications for Bayesian Semiparametric Survival Analysis
Blog
Jan 15, 2025, 11:08
Why Dana-Farber Direct Connect? - Dana-Farber Cancer Institute
Blog
Jan 15, 2025, 10:56
Sachin H. Jain: The path forward for the US Health Insurance Industry begins with saying “We Are Sorry”
Blog
Jan 15, 2025, 08:23
Pashtoon Kasi: Different kind of liquid biopsies in guiding care of patients with cancer